Back to search results

AtorvaStatin Postpartum and Reduction of Cardiovascular risK

Abroad (travel likely)RecruitingPHASE4

Conditions

Hypertensive Disorders of Pregnancy · Preeclampsia · Gestational Hypertension

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus, Ohio, United States

    Contact: Study coordinator (Maged Costantine, MD, MBA) · Maged.Costantine@osumc.edu · 614-293-2222
    Contact: Study coordinator (Kara Rood, MD) · Kara.Rood@osumc.edu · 614-293-8045
    Contact: Principal Investigator (Kara Rood, MD)
    Contact: Principal Investigator (Maged Costantine, MD, MBA)
    Lauren Hassen, MD (Sub-investigator)
    Sydney Lammers, MD (Sub-investigator)
Study leads

  • Tracy C Bank, MD

    Principal Investigator

    Ohio State University

View source on ClinicalTrials.gov(opens in a new tab)